艾滋病药物绥美凯的价格

It was approved by the US FDA in 2014 for the treatment of adults and adolescents over 12 years old (with a weight of at least 40kg) infected with human immunodeficiency virus (HIV). This is currently the only three-in-one combination drug containing dolutegravir (DTG), which integrates treatment drugs for different stages of viral infection in the same tablet. Patients only need to take one drug to achieve the effect of combined medication.

In 2018, Suimeikan was approved for sale in my country, bringing new solutions to the treatment of domestic AIDS patients. The price of Suimeikan in China is about $3,000 per month. For many patients, the financial pressure is relatively high if they purchase and use it for a long time. You may wish to choose Suimeikai produced by the Indian company Emcure. A box of 30 tablets is priced at around 900 US dollars. It is relatively cost-effective. The price may change due to various factors such as exchange rates. Patients can consult the medical companion and travel service for specific information.

Suimeikai mainly contains three ingredients, namely dolutegravir 50mg + abacavir 0.6g + lamivudine 0.3g. The method of use of Suimeikai is simple. One tablet a day can achieve the effect of cocktail therapy without food restrictions, which greatly improves the patient's medication compliance. In terms of therapeutic effect, it can also significantly inhibit the virus, has smaller side effects, and is less likely to develop drug resistance.

For adults and adolescents over 12 years of age, the recommended dosage is one tablet, once daily. Moreover, Suimeikai tablets have a fixed dose and cannot be adjusted, and cannot be used by patients under 40kg. Prior to initiating treatment, HLA-B*5701 status must be confirmed as this patient is at higher risk of developing abacavir hypersensitivity reactions.

Recommended related hot articles: /newsDetail/80774.html